5 Key Takeaways
-
1
AI can optimize treatment for neovascular age-related macular degeneration by reducing both undertreatment and overtreatment.
-
2
The study utilized two different OCT systems to ensure AI accuracy across various imaging devices and mitigate domain shift.
-
3
AI is expected to function as a decision-making support tool, enhancing clinician decision-making rather than operating autonomously.
-
4
Patient trust in AI is crucial, and positive engagement has been observed when AI prioritizes safety and health equity.
-
5
AI-enabled OCT analysis is being successfully implemented in teleophthalmology, providing eye care in underserved and remote areas.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
